Navigation Links
Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur

n. It is designed to instruct the patient’s immune system to produce an antibody response against angiotensin II. Angiotensin II is a small peptide in the body and part of the so-called renin-angiotensin system (RAS), an important regulator of blood pressure. Angiotensin II causes blood vessels to narrow,
resulting in increased blood pressure. In a phase IIa clinical trial, vaccination with CYT006-AngQb has been shown to reduce blood pressure by induction of antibodies that bind angiotensin II. Thereby, binding of angiotensin II to its receptors and subsequent narrowing of blood vessels should be decreased. The RAS has already been successfully targeted by three major classes of antihypertensive drugs on the market: inhibitors of the angiotensin-converting-enzyme (ACE), antagonists of the angiotensin II type I receptor (ARBs) and renin inhibitors. Like other antihypertensive drugs these also come with the need for daily dosing and fail to provide a solution for improving patient compliance. Treatment with CYT006-AngQb should allow for convenient dosing schedules and smooth control of blood pressure due to a sustained antibody response induced by vaccination.



About Cytos Biotechnology AG
Cytos Biotechnology AG is a public Swiss biotechnology company that specializes in the discovery, development and commercialization of a new class of biopharmaceutical products – the ImmunodrugsTM. ImmunodrugsTM are intended for use in the treatment and prevention of common chronic diseases, which afflict millions of people worldwide. ImmunodrugsTM are designed to instruct the patient’s immune system to produce desired therapeutic antibody or T cell responses that modulate chronic disease processes. Taking advantage of the high flexibility of its ImmunodrugTM platform, Cytos Biotechnology has built a pipeline of different ImmunodrugTM candidates in various disease areas, of which 6 are currently in clinical development. The Imm
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
2. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
3. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
4. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
5. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
6. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
7. New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard Therapy in Treatment of Hypertension
8. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
9. King Pharmaceuticals Announces Plan to Present Results from Phase III Clinical Trial Evaluating ALTACE as Monotherapy and in Combination with Hydrochlorothiazide at the American Society of Hypertension Annual Meeting
10. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
11. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
Post Your Comments:
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets ... and Development Trend Forecast of Pharmaceutical Equipment Market in ... Research and Development Trend Forecast of Pharmaceutical Equipment ... analyzes China,s pharmaceutical equipment industry ... demand, competition landscape, and business performance of domestic major ...
(Date:8/29/2014)... 2014 According to the ... Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User ... Gene Synthesis, NGS, DNA, RNAi) - Global Forecast ... Synthesis Market is expected to reach $1,712.1 Million ... at a CAGR of 9.8% from 2014 to ...
(Date:8/29/2014)... 2014 /PRNewswire-iReach/ -- ChemImage will present a workshop focused ... Zealand Forensic Science Society,s 22 nd International ... Adelaide, Australia .  Forensic Scientists will be ... hyperspectral imaging can bring to examination procedures. ... of Product Development at ChemImage, will host a ...
Breaking Medicine Technology:Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
(Date:9/1/2014)... Although cannabis commonly known as marijuana ... by Massachusetts General Hospital (MGH) investigators found that ... for substance use disorder reported experiencing symptoms of ... dependence. Study participants reporting withdrawal were more ... and for mood disorders, although the presence or ...
(Date:9/1/2014)... 02, 2014 iFitDress.com, a professional company ... its new selection of modest evening dresses . ... cuts on these great evening gowns. All customers can ... August 16, 2014. , iFitDress.com is one of ... designers and production workers are striving to create more ...
(Date:9/1/2014)... “Australia Hernia Repair Market Outlook to ... Repair market. The report provides value, in millions of ... US dollars) within market segments –, ... ,     Composite Meshes and Biological Meshes. ... the correction of a hernia (a bulging of internal ...
(Date:9/1/2014)... (HealthDay News) -- Having regular family meals may help ... "cyberbullying," a new study suggests. Online abuse can ... experts. "One in five adolescents experience cyberbullying," Frank ... Social Policy at McGill University in Montreal, said in ... media, and online harassment and abuse are difficult for ...
(Date:9/1/2014)... with mental health and substance use problems in ... from the consequences of cyberbullying and also be ... J. Elgar, Ph.D., of McGill University, Montreal, Canada, ... adolescents has experienced recent online bullying and cyberbullying, ... mental health problems in teens as well as ...
Breaking Medicine News(10 mins):Health News:Cannabis withdrawal symptoms common among adolescents treated for substance use disorder 2Health News:Cannabis withdrawal symptoms common among adolescents treated for substance use disorder 3Health News:iFitDress.com: New Modest Evening Wear Selection Now Unveiled Online 2Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 2Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 3Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 4Health News:Family Meals May Defuse Cyberbullying's Impact, Study Says 2Health News:Family dinners good for teens' mental health, could protect from cyberbullying 2Health News:Family dinners good for teens' mental health, could protect from cyberbullying 3
... , LYSOL(R) Helps Protect Families by Killing 99.9% of Illness-Causing Bacteria ... Your family may not be the only ones getting comfy and ... relax and play at home can harbor thousands of bacteria. ... bacteria can live on them for months.(1) , ...
... ... determine the extent of drowsy Truck Drivers, Bus Drivers, Commuter Train Operators, Airline Pilots, ... ... Snoring Isn,t Sexy ® announces the launch of an anonymous, confidential survey to ...
... recipients to suppress their immune systems, has a paradoxical effect ... Vaccine Center have discovered. In experiments conducted in both ... CD8 T cells, which enable the immune system to respond ... encounter. The results were published online ahead of print ...
... Improved care and overall better health are credited with improved ... having a heart attack for the first time are more ... ago, researchers have confirmed. , But now doctors are ... survivable -- what doctors, hospitals and individuals are doing right, ...
... and implantable cardiac devices in Europe was presented on Sunday ... Heart Rhythm Association (EHRA) 1 which takes place in ... and figures, including the current status of healthcare systems across ... . "This document is intended to be the starting ...
... frail elderly and disabled Ohioans , , COLUMBUS, ... Coalition, consisting of the three organizations representing Ohio,s skilled ... frail elderly and disabled Ohioans, today expressed their alarm ... Friday. , , "While we respect the Governor,s ...
Cached Medicine News:Health News:Harmful Bacteria May Hide on Soft Surfaces in Your Home 2Health News:Snoring Isn't Sexy, LLC Launches Survey to Determine Extent of Drowsy Drivers on Land, Sea and In The Air 2Health News:Transplant drug stimulates immune memory 2Health News:Heart Attacks Less Often Fatal Today 2Health News:Heart Attacks Less Often Fatal Today 3Health News:Big disparities in the treatment of arrhythmias across Europe 2Health News:Big disparities in the treatment of arrhythmias across Europe 3Health News:Big disparities in the treatment of arrhythmias across Europe 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: